Used as a key intermediate in the synthesis of selective kinase inhibitors, particularly in the development of anticancer agents. Its structure allows for strong binding to specific enzyme targets involved in cell signaling pathways, making it valuable in pharmaceutical research. Commonly employed in the optimization of drug candidates targeting tyrosine kinases and other ATP-binding site inhibitors. Also utilized in structure-activity relationship (SAR) studies to improve potency and selectivity of therapeutic compounds.